Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER
Aim. To study the dynamics of the lipid profile of hypertensive patients with dyslipidemia who underwent COVID-19.Material and methods. Hypertensive patients with dyslipidemia who underwent COVID-19 [n=126; 58 men and 68 women; median age 60 (56.0; 65.5) years] examined. Patients were included into...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2022-07-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2750 |